Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 236 Lymphoma 176 Lymphoma, Large B-Cell, Diffuse 171 Precursor Cell Lymphoblastic Leukemia-Lymphoma 84 Lymphoma, Follicular 77 Lymphoma, Non-Hodgkin 72 Burkitt Lymphoma 66 Multiple Myeloma 62 Leukemia 57 Hodgkin Disease 45 Lymphoma, Mantle-Cell 41 Neoplasms 34 Lymphoma, T-Cell, Peripheral 31 Lymphoma, B-Cell 30 Lymphoma, B-Cell, Marginal Zone 27 Lymphoma, Large-Cell, Anaplastic 26 Lymphoma, Large-Cell, Immunoblastic 24 Neoplasm Metastasis 23 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22 Leukemia, Lymphocytic, Chronic, B-Cell 22 Neoplasms, Plasma Cell 21 Recurrence 19 Immunoblastic Lymphadenopathy 15 Dendritic Cell Sarcoma, Interdigitating 15 Lymphoma, T-Cell 14 Leukemia, Biphenotypic, Acute 10 Waldenstrom Macroglobulinemia 9 Blast Crisis 9 Primary Myelofibrosis 8 Myelodysplastic Syndromes 8

Interventions

Methylprednisolone 3 Etanercept 2 tocilizumab 1 pirfenidone 1 ceftolozane, tazobactam drug combination 1 XAV-19 1 Ultrasonography 1 Standard of Care 1 Sodium Bicarbonate 1 Saline Solution 1 Ribavirin 1 Prednisone 1 Nebulizers and Vaporizers 1 Lidocaine 1 Immunoglobulin G 1 Gelsolin 1 Fluoridation 1 Disulfides 1 Clinical Protocols 1 Calcitriol 1 CIMAvax EGF 1 Blood Specimen Collection 1 Amifostine 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pneumonia × Prednisone × Clear all

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡